[Alzheimer disease and tau protein].
[Alzheimer disease and tau protein].
复制标题
[阿尔茨海默病和 tau 蛋白]。
DOI:
10.5692/clinicalneurol.52.1171
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
M. Takeda
中科院分区:
文献类型:
--
作者:
Toshihisa Tanaka;Daisuke Mayuyama;M. Takeda
To elucidate involvement of tau protein in neurodegenerative processes in Alzheimer disease and related disorders, self-assembly process and degradative process of tau protein were examined. To understand the mechanisms of the aggregation, binding affinity of tau protein to 14-3-3 protein, which converts tau to a filamentous or aggregated form. was investigated employing a surface plasmon resonance assay. Phosphorylation of tau by protein kinase A increased affinity of tau to 14-3-3, whereas the phosphorylation attenuated formation of filaments or aggregates. FTDP-17 mutation increased affinity of unphosphorlated tau to 14-3-3, compared to wild typed unphosphorylated tau. However the phosphorylation increased its affinity further to the similar level of the affinity of phosphorylated wild typed tau. Similarly the phosphorylation also attenuated formation of filaments or aggreeagates from FTDP-17 mutated tau. To understand the mechanisms of the intracellular accumulation, possible involvement of proteases were studied. Among several proteases, puromycin-sensitive aminopeptidase (PSA) was found as a predominant regulator of degradation of tau protein. In addition FTDP-17 mutation increased phosphorylation of tau proten in cells, and attenuated intracellular degradation of tau protein. These results suggest that self-assembly and accumulation of tau protein are regulated by phosphorylation, and FTDP-17 mutation affects those complexed processes.
影响因子:
4.7
作者:
Sadik, Golam;Tanaka, Toshihisa;Takeda, Masatoshi
通讯作者:
Takeda, Masatoshi
影响因子:
2
作者:
Kentarou Yanagi;Toshihisa Tanaka;Kiyoko Kato;G. Sadik;T. Morihara;T. Kudo;M. Takeda
通讯作者:
M. Takeda